No offense taken. I think we all walk a fine line sometimes. I was just posting some of the benefits of adding Hydroxyzine and Zofran to my Opana. Some of these may work for you also.
Hydroxyzine is used primarily as an antihistamine for the treatment of itching, allergies, hyperalgesia, motion sickness-induced nausea, and insomnia, as well as notably for the treatment of mild anxiety. Even though it is an effective sedative, hypnotic, analgesic, and tranquilizer, it shares almost none of the abuse, dependence, addiction, and toxicity potential of other drugs used for the same range of therapeutic reasons.
Hydroxyzine is used with opioid analgesics to increase the pain-killing ability of a given dose of opioid, reduce the quantity needed to stop a given level of pain, and/or preempt some side effects of opiates, like itching, nausea, and vomiting.
Hydroxyzine was found to have no adverse effects on memory in relation to lorazepam, which caused several deficiencies in the capacity of memory storage.
In a comparative study with lorazepam on memory effects, patients who had taken Hydroxyzine experienced sedative effects similar to drowsiness, but recalled that they felt capable, attentive and able to continue with a memory test under these conditions. Conversely, those under the effects of lorazepam felt unable to continue due to the fact they felt out of control due to its effects.
_______________>> Zofran (Ondansetron)
Ondansetron is a 5-HT3 receptor antagonist used primarily to treat and prevent chemotherapy-induced nausea and vomiting.
Ondansetron may have value in the treatment of schizophrenia and Obsessive Compulsive Disorder.
A patent for the use of Ondansetron in the treatment of Sleep Apnea has been filed.
Ondansetron has been studied as a possible treatment for psychosis resulting from advanced Parkinson's disease.
Ondansetron lowers the cravings for alcohol, especially in early-onset alcoholics.
Ondansetron has been found to be useful and effective for treating withdrawal symptoms of Opioid addictions.
Ondansetron blocks the 5-HT3 receptor in the enteric nervous system, and thereby reduces colonic contractions, sensory perception, and hyper-motility found in Inflammatory Bowel Syndromes.